• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: EKOS CORPORATION EKOSONIC ENDOVASCULAR CATHETER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

EKOS CORPORATION EKOSONIC ENDOVASCULAR CATHETER Back to Search Results
Model Number UNKNOWN
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem Atrial Fibrillation (1729)
Event Date 12/03/2018
Event Type  Injury  
Manufacturer Narrative
The patient experienced atrial fibrillation following the removal of the ekos catheters following an 8 hour treatment for a bilateral pe.The treatment stopped on (b)(6) 2018 at 01:29 and the patient experienced a-fib at 05:30.The time the catheters were removed from the patient was not reported.Cardiac arrhythmias are a potential complication listed in the ifu most frequently occurring during placement, removal or following displacement into the right ventricle.This clinical study sae is considered to be procedure-related and not related to the ekos device.No additional information will be available.
 
Event Description
Subject (b)(6) is a retrospective patient enrolled in the (b)(6) study - (b)(6).This patient is a (b)(6) female.Clinical history and risk factors were reported (b)(6) with a 31.7 bmi; baseline 12 lead ecg was completed with abnormal results: "a-fib incomplete right bbb nonspecific st and t was abnormalities".This patient has a history of high cholesterol, hypertension, bmi>30.0.This patient was treated for a bilateral pe on (b)(6) 2018 for approximately 8 hours.12 mg of tpa were administered through each device (left pulmonary and right pulmonary arteries).The planned therapy was completed at 01:29 on (b)(6) 2018.The sae (new onset of moderate atrial fibrillation) started at 05:30 on (b)(6) 2018 and resolved on 15:15 (b)(6) 2018 and resulted in the need for non-surgical drug treatment, cardioversion and prolongation of hospitalization.The principle investigator classified the relationship of the new onset of atrial fibrillation as not related to the ekos device, thrombolytic drug and anticoagulant drug, but reported the relationship between the event and the interventional procedure as unknown.
 
Manufacturer Narrative
This is a follow up #1 to update the principle investigator's assessment of relatedness to the interventional procedure and to update the conclusion code accordingly.On 11 feb 2019, the principle investigator updated the relationship between the event and the interventional procedure from unknown to not related.This event (atrial fibrillation) is not related to the interventional procedure or the ekos device.The cause of the atrial fibrillation is unknown.
 
Event Description
This is a follow up #1 to update the principle investigator's assessment of relatedness to the interventional procedure and to update the conclusion code accordingly.On 11 feb 2019, the principle investigator updated the relationship between the event and the interventional procedure from unknown to not related.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
EKOSONIC ENDOVASCULAR CATHETER
Type of Device
CATHETER
Manufacturer (Section D)
EKOS CORPORATION
11911 north creek parkway s
bothell WA 98011 8809
MDR Report Key8370744
MDR Text Key137167961
Report Number3001627457-2019-00007
Device Sequence Number1
Product Code KRA
Combination Product (y/n)N
PMA/PMN Number
K182324
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type health professional,study
Type of Report Initial,Followup
Report Date 02/01/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received02/26/2019
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model NumberUNKNOWN
Was Device Available for Evaluation? No
Date Manufacturer Received02/11/2019
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Hospitalization;
Patient Age57 YR
-
-